O'Brien Megan A MA

Show results for

Unknown (9)
Transcriptomics (1)
Metabolomics (1)

Organisms

Mus musculus (1)

Repository

biostudies-arrayexpress (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Q Exactive (1)

Publication Date

2016 (1)
2021 (1)

CHEBI ID

CHEBI:10072 (1)
CHEBI:10362 (1)
CHEBI:131434 (1)
CHEBI:132188 (1)
CHEBI:132948 (1)
CHEBI:132966 (1)
CHEBI:132983 (1)
CHEBI:133005 (1)
CHEBI:133026 (1)
CHEBI:133028 (1)
CHEBI:133032 (1)
CHEBI:133046 (1)
CHEBI:133066 (1)
CHEBI:133089 (1)
CHEBI:133092 (1)
CHEBI:133096 (1)
CHEBI:133115 (1)
CHEBI:133119 (1)
CHEBI:133172 (1)
CHEBI:133176 (1)
CHEBI:133181 (1)
CHEBI:133185 (1)
CHEBI:133186 (1)
CHEBI:133197 (1)
CHEBI:133199 (1)
CHEBI:133223 (1)
CHEBI:133435 (1)
CHEBI:133459 (1)
CHEBI:133460 (1)
CHEBI:133469 (1)

Metabolite Name

(R)-3-hydroxybutyrylcarnitine (1)
1-linoleoyl-GPA (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylhistidine (1)
1-methylnicotinamide (1)
12,13-DiHOME (1)
16a-hydroxy DHEA 3-sulfate (1)
2'-O-methylcytidine (1)
2'-O-methyluridine (1)
2'-deoxyuridine (1)
2,3-dihydroxyisovalerate (1)
2,6-dihydroxybenzoic acid (1)
2-aminoadipate (1)
2-aminobutyrate (1)
2-aminoheptanoate (1)
2-aminooctanoate (1)
2-aminophenol sulfate (1)
2-hydroxy-3-methylvalerate (1)
2-hydroxyacetaminophen sulfate* (1)
2-hydroxyadipate (1)
2-hydroxybutyrate/2-hydroxyisobutyrate (1)
2-hydroxydecanoate (1)
2-hydroxyglutarate (1)
2-hydroxyibuprofen (1)
2-hydroxynervonate* (1)
2-hydroxyoctanoate (1)
2-hydroxypalmitate (1)
2-hydroxyphenylacetate (1)
2-hydroxystearate (1)
2-isopropylmalate (1)

Study type

RNA-seq of coding RNA (1)

Release Date

2022 (3)
2021 (3)
2023 (2)
2016 (1)
2025 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepository

INTRODUCTION: Acute lymphoblastic leukemia (ALL) is among the most common cancers in children. With improvements in combination chemotherapy regimens, the overall survival has increased to over 90%. However, the current challenge is to mitigate adverse events resulting from the c...

2021-08-12 | MTBLS2394 | MetaboLights

Alterations to the Synaptic Transcriptome in Response to Ethanol-Induced Behavioral Sensitization in DBA/2J Mice

Alcoholism is a complex neurological disorder characterized by loss of control in limiting intake, and progressive compulsion to seek and consume ethanol. Prior studies have suggested that the characteristic behaviors associated with escalation of drug use are caused, at least in part, by ethanol-ev...

ORGANISM(S): Mus musculus

2016-09-01 | E-GEOD-73018 | biostudies-arrayexpress

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC7884931 | biostudies-literature

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8084355 | biostudies-literature

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8598213 | biostudies-literature

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.